INCOME STATEMENT (Annual GAAP In millions $) |
(Apr 30 2024) 2024 |
(Apr 30 2023) 2023 |
(Apr 30 2022) 2022 |
(Apr 30 2021) 2021 |
(Apr 30 2020) 2020 |
Revenue From Contract With Customer Excluding Assessed Tax |
0.19 |
0.26 |
0.25 |
0.26 |
0.32 |
Other Revenue |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
Total Revenue |
0.19 |
0.26 |
0.25 |
0.26 |
0.32 |
Cost of Goods and Services Sold |
0.04 |
0.04 |
0.04 |
0.06 |
0.06 |
Gross
Profit |
0.16 |
0.21 |
0.20 |
0.20 |
0.26 |
Selling, Administration, Marketing |
0.18 |
0.25 |
1.20 |
1.39 |
1.05 |
Depriciation & Amortization |
- |
- |
- |
- |
0.01 |
Research and Development Expense |
- |
- |
0.22 |
- |
- |
Restructuring, Accretion & impairment charges |
- |
- |
- |
- |
- |
Other operatinig exp. /-income |
0.69 |
0.85 |
0.05 |
- |
0.85 |
Legal Fees |
0.07 |
0.08 |
- |
- |
- |
Derivative Gain Loss On Derivative Net |
- |
- |
- |
- |
-0.86 |
Fees and Commission |
0.07 |
0.43 |
- |
- |
- |
Total operating costs including COS |
1.06 |
1.65 |
1.51 |
1.46 |
1.11 |
Operating income/-loss
|
-0.86 |
-1.39 |
-1.27 |
-1.20 |
-0.79 |
Other Deductions / - Income |
Interest expense |
- |
- |
- |
- |
- |
Interest income |
- |
- |
- |
- |
- |
Net interest expense/-income |
- |
- |
- |
- |
- |
Loss/ -Gain on Investment |
- |
- |
- |
- |
- |
Foreign Currency Transaction (Gain) Loss |
- |
- |
- |
- |
- |
Allowances, Health Care Trust Fund And Other |
- |
- |
- |
- |
- |
Unexpected (Gain) Loss |
- |
- |
- |
- |
- |
Other loss/ -income |
-0.26 |
-2.42 |
7.12 |
0.50 |
-0.02 |
Debt Instrument Decrease Forgiveness |
- |
- |
- |
-0.13 |
- |
Financing Cost |
- |
- |
0.60 |
0.72 |
- |
Total costs & expenses |
0.80 |
-0.77 |
9.23 |
2.55 |
1.09 |
Income /-loss before income taxes |
-0.61 |
1.03 |
-8.99 |
-2.29 |
-0.77 |
Income taxes expenses/-benefit |
- |
- |
- |
- |
- |
Income after income taxes |
-0.61 |
1.03 |
-8.99 |
-2.29 |
-0.77 |
Net income/-loss
of other equity |
- |
- |
- |
- |
- |
Income/-loss
from cont. Ops. |
-0.61 |
1.03 |
-8.99 |
-2.29 |
-0.77 |
Accounting change |
- |
- |
- |
- |
- |
Discontinued operations |
- |
- |
- |
- |
- |
Extraordinary items |
- |
- |
- |
- |
- |
Net Income/-loss |
-0.61 |
1.03 |
-8.99 |
-2.29 |
-0.77 |
Noncontrolling interests |
-0.04 |
-0.01 |
0.00 |
-0.01 |
-0.01 |
Prefered dividends |
- |
- |
- |
0.00 |
0.00 |
Other |
- |
- |
- |
- |
- |
Income/-loss to shareholder |
-0.64 |
1.02 |
-8.99 |
-2.30 |
-0.79 |
EBIT |
-0.61 |
1.03 |
-8.99 |
-2.29 |
-0.77 |
EBITD |
-0.61 |
1.03 |
-8.99 |
-2.29 |
-0.77 |
EBITDA |
-0.61 |
1.03 |
-8.93 |
-1.57 |
-0.24 |